Page last updated: 2024-09-04

ezetimibe and Peripheral Arterial Diseases

ezetimibe has been researched along with Peripheral Arterial Diseases in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (77.78)	24.3611
2020's	2 (22.22)	2.80

Authors

Authors	Studies
Armstrong, DG; Fernando, ME; Golledge, J	1
Mühlberg, KS	1
Athyros, VG; Giannoukas, AD; Katsiki, N; Mikhailidis, DP	1
Ballantyne, CM; Brunner, G; Chen, C; Dong, JF; Hoogeveen, RC; Kougias, P; Kumar, A; Lin, PH; Lumsden, AB; Morrisett, JD; Murray, T; Nambi, V; Negi, SI; Sun, W; Taylor, A; Virani, SS; Yang, EY	1
Ballantyne, CM; Dong, JF; Kimball, KT; Lumsden, AB; Morrisett, JD; Nambi, V; Saunders, J; Virani, SS	1
Anderson, JD; Berr, SS; Chew, JD; Christopher, JM; DiMaria, JM; Epstein, FH; Hagspiel, KD; Harthun, NL; Hunter, JR; Kramer, CM; Meyer, CH; Wang, H; West, AM; Winberry, GB	1
Taylor, AJ	1
Jones, WS; Krucoff, MW; Patel, MR	1
Anderson, JD; Berr, SS; Christopher, JM; Dimaria, JM; Epstein, FH; Hagspiel, KD; Harthun, NL; Hunter, JR; Kramer, CM; Meyer, CH; Wang, H; Weltman, AL; West, AM	1

Reviews

2 review(s) available for ezetimibe and Peripheral Arterial Diseases

Article	Year
Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy. Drugs, 2022, Volume: 82, Issue:11 Topics: Cholesterol, LDL; Ezetimibe; Humans; Peripheral Arterial Disease; Proprotein Convertase 9; Risk Factors	2022
Lipid-lowering treatment in peripheral artery disease. Current opinion in pharmacology, 2018, Volume: 39 Topics: Animals; Cholesterol Ester Transfer Proteins; Ezetimibe; Fibric Acids; Humans; Hypolipidemic Agents; Niacin; PCSK9 Inhibitors; Peripheral Arterial Disease	2018

Trials

4 trial(s) available for ezetimibe and Peripheral Arterial Diseases

Article	Year
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis, 2013, Volume: 231, Issue:2 Topics: Aged; Azetidines; Cholesterol; Double-Blind Method; Endothelium, Vascular; Ezetimibe; Female; Femoral Artery; Humans; Lipids; Lipoproteins; Magnetic Resonance Imaging; Male; Middle Aged; Niacin; Peripheral Arterial Disease; Simvastatin	2013
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients. Journal of vascular surgery, 2011, Volume: 53, Issue:3 Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arachidonic Acid; Aspirin; Azetidines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lower Extremity; Male; Middle Aged; Niacin; Peripheral Arterial Disease; Placebo Effect; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Stents; Time Factors; Treatment Outcome	2011
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis, 2011, Volume: 218, Issue:1 Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Azetidines; Cholesterol, LDL; Double-Blind Method; Ezetimibe; Female; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Middle Aged; Peripheral Arterial Disease; Plaque, Atherosclerotic; Prospective Studies; Simvastatin; Treatment Outcome	2011
Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. Journal of the American College of Cardiology, 2011, Aug-30, Volume: 58, Issue:10 Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Energy Metabolism; Exercise Test; Exercise Tolerance; Ezetimibe; Female; Humans; Leg; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Peripheral Arterial Disease; Phosphocreatine; Simvastatin	2011

Other Studies

3 other study(ies) available for ezetimibe and Peripheral Arterial Diseases

Article	Year
[Update on lipid lowering therapy in peripheral artery disease]. Deutsche medizinische Wochenschrift (1946), 2023, Volume: 148, Issue:22 Topics: Adult; Anticholesteremic Agents; Cholesterol, LDL; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Peripheral Arterial Disease; Proprotein Convertase 9	2023
Another clinical evidence straw on the $4 billion ezetimibe camel's back. Atherosclerosis, 2011, Volume: 218, Issue:1 Topics: Atherosclerosis; Azetidines; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Peripheral Arterial Disease	2011
Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease. Journal of the American College of Cardiology, 2011, Aug-30, Volume: 58, Issue:10 Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Leg; Male; Peripheral Arterial Disease; Simvastatin	2011